InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Pieper Steven, Chief Financial Officer. Director active across 2 companies, notably Xeris Pharmaceuticals INC. Aggregated, 10 disclosures have been logged. Total volume traded: €86k. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations10 total
0200,000 shares0
Common Stock
SEC:0001867096-22-000012·
0200,000 shares0
Common Stock
SEC:0001867096-22-000012:0·
€43,04925,000 shares@ €1.7220.0033% mcap100.0% of flow
Common Stock
SEC:0001867096-21-000075·
Ideal exit: 7 Aug 2022 (T+270)
€43,04925,000 shares@ €1.7220.0033% mcap50.0% of flow
Common Stock
SEC:0001867096-21-000075:0·
Ideal exit: 7 Aug 2022 (T+270)
23,775 shares
Common Stock
SEC:0000899243-21-039253·
23,775 shares
Common Stock
SEC:0000899243-21-039324·
23,775 shares
Common Stock
SEC:0000899243-21-039324:0·
23,775 shares
Common Stock
SEC:0000899243-21-039253:0·
0100,000 shares0
Common Stock
SEC:0000899243-21-030664·
0100,000 shares0
Common Stock
SEC:0000899243-21-030664:0·
10 of 10 declarations
About Pieper Steven
Pieper Steven is Chief Financial Officer at XERIS PHARMACEUTICALS INC and Xeris Biopharma Holdings, Inc. In this role, he is responsible for financial management and budgeting strategy for these companies. His expertise in finance allows him to optimize financial performance and ensure regulatory compliance. Steven plays a key role in strategic planning and financial results analysis.
